ALT
Altimmune, Inc.Company with tickers: ALT
CIK
1326190
CUSIP
02155H200
Shares Outstanding
194,474,154
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $24,244,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $16,192,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-24,244,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-22,563,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |